Beyond Steroids: The New Era of Chronic GVHD Therapy

This event is in association with HOPA 2026.

Meeting Objectives:

• • Evaluate recent evidence and therapeutic advances in chronic GVHD and their implications for everyday clinical decision-making.  
  • Apply updated therapeutic guidelines and clinical evidence to real-world case scenarios, emphasizing individualized and evidence-based care
  • Explore the pharmacist’s role in optimizing adherence, managing adverse effects, and addressing access barriers in cGVHD care.